Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr 15;117(8):1560-3.
doi: 10.1002/cncr.25716. Epub 2010 Nov 10.

Melanoma's deadly march to the brain: by what route, and can it be stopped?

Editorial

Melanoma's deadly march to the brain: by what route, and can it be stopped?

Megan Othus et al. Cancer. .

Abstract

Melanoma patients who develop brain metastasis have a very poor prognosis, in part because of relative resistance to external beam radiotherapy and in part due to the low activity and poor CNS penetration of the available systemic agents. Three articles in this issue of Cancer summarize retrospective analyses of melanoma patients with brain metastasis. While the three articles investigate similar questions, each article considers different patient characteristics, and the results of the articles provide different and diverging conclusions. We will summarize the results and authors’ conclusions from each of the three articles, examine potential limitations of each article’s conclusions, try to synthesize the results of the three articles, and conclude with ideas for future research.

PubMed Disclaimer

Comment on

References

    1. Zakrzewski J, Geraghty LN, Rose AE, et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastasis and post-brain metastasis survival. Cancer. 2011;116:1711–1720. - PMC - PubMed
    1. Eigentler TK, Figl A, Krex D, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer. 2011;116:1697–1703. - PubMed
    1. Davies MA, Liu P, McIntyre S, et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer. 2011;116:1687–1696. - PubMed
    1. Balch CM, Buzaid AC, Soong S-J, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001;19(16): 3635–48. - PubMed
    1. Kruijff S, Bastiaannet E, Muller Kobold A, van Ginkel R, Suurmeijer A, Hoekstra H. Erratum to: S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients. Annals of Surgical Oncology 2010: 1–1. - PMC - PubMed